vs
MSC INDUSTRIAL DIRECT CO INC（MSM）与通用电气医疗（OPCH）财务数据对比。点击上方公司名可切换其他公司
通用电气医疗的季度营收约是MSC INDUSTRIAL DIRECT CO INC的1.5倍（$1.4B vs $965.7M），MSC INDUSTRIAL DIRECT CO INC净利率更高（5.4% vs 3.6%，领先1.8%），通用电气医疗同比增速更快（12.2% vs 4.0%），通用电气医疗自由现金流更多（$130.2M vs $7.4M），过去两年通用电气医疗的营收复合增速更高（13.0% vs -3.4%）
MSC工业直销公司（MSC）通过旗下主要子公司MSC工业供应公司，是美国规模最大的工业设备分销商之一，可提供超过150万种金属加工及其他工业类产品，广泛服务于工业制造、维修运维等领域的客户需求。
通用电气医疗是总部位于美国伊利诺伊州芝加哥的医疗科技企业，旗下设四大业务板块：医学影像（含分子成像、CT、磁共振、女性健康筛查及X线设备）、超声、患者护理解决方案（覆盖远程患者监测、麻醉呼吸护理、心脏病诊断、婴儿护理等）及制药相关业务。
MSM vs OPCH — 直观对比
营收规模更大
OPCH
是对方的1.5倍
$965.7M
营收增速更快
OPCH
高出8.2%
4.0%
净利率更高
MSM
高出1.8%
3.6%
自由现金流更多
OPCH
多$122.8M
$7.4M
两年增速更快
OPCH
近两年复合增速
-3.4%
损益表 — Q1 FY2026 vs Q3 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $965.7M | $1.4B |
| 净利润 | $51.8M | $51.8M |
| 毛利率 | 40.7% | 19.0% |
| 营业利润率 | 7.9% | 5.9% |
| 净利率 | 5.4% | 3.6% |
| 营收同比 | 4.0% | 12.2% |
| 净利润同比 | 11.1% | -3.8% |
| 每股收益（稀释后） | $0.93 | $0.32 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收MSMOPCH
| Q4 25 | $965.7M | — | ||
| Q3 25 | $978.2M | $1.4B | ||
| Q2 25 | $971.1M | $1.4B | ||
| Q1 25 | — | $1.3B | ||
| Q4 24 | $928.5M | $1.3B | ||
| Q3 24 | — | $1.3B | ||
| Q2 24 | $979.4M | $1.2B | ||
| Q1 24 | $935.3M | $1.1B |
净利润MSMOPCH
| Q4 25 | $51.8M | — | ||
| Q3 25 | $56.5M | $51.8M | ||
| Q2 25 | $56.8M | $50.5M | ||
| Q1 25 | — | $46.7M | ||
| Q4 24 | $46.6M | $60.1M | ||
| Q3 24 | — | $53.9M | ||
| Q2 24 | $71.7M | $53.0M | ||
| Q1 24 | $61.8M | $44.8M |
毛利率MSMOPCH
| Q4 25 | 40.7% | — | ||
| Q3 25 | 40.4% | 19.0% | ||
| Q2 25 | 41.0% | 19.0% | ||
| Q1 25 | — | 19.7% | ||
| Q4 24 | 40.7% | 21.3% | ||
| Q3 24 | — | 20.1% | ||
| Q2 24 | 40.9% | 20.3% | ||
| Q1 24 | 41.5% | 20.8% |
营业利润率MSMOPCH
| Q4 25 | 7.9% | — | ||
| Q3 25 | 8.6% | 5.9% | ||
| Q2 25 | 8.5% | 5.8% | ||
| Q1 25 | — | 5.9% | ||
| Q4 24 | 7.8% | 6.9% | ||
| Q3 24 | — | 6.7% | ||
| Q2 24 | 10.9% | 6.6% | ||
| Q1 24 | 9.7% | 6.0% |
净利率MSMOPCH
| Q4 25 | 5.4% | — | ||
| Q3 25 | 5.8% | 3.6% | ||
| Q2 25 | 5.9% | 3.6% | ||
| Q1 25 | — | 3.5% | ||
| Q4 24 | 5.0% | 4.8% | ||
| Q3 24 | — | 4.2% | ||
| Q2 24 | 7.3% | 4.3% | ||
| Q1 24 | 6.6% | 3.9% |
每股收益（稀释后）MSMOPCH
| Q4 25 | $0.93 | — | ||
| Q3 25 | $1.02 | $0.32 | ||
| Q2 25 | $1.02 | $0.31 | ||
| Q1 25 | — | $0.28 | ||
| Q4 24 | $0.83 | $0.36 | ||
| Q3 24 | — | $0.31 | ||
| Q2 24 | $1.27 | $0.30 | ||
| Q1 24 | $1.10 | $0.26 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $40.3M | $309.8M |
| 总债务越低越好 | $214.1M | $1.2B |
| 股东权益账面价值 | $1.4B | $1.4B |
| 总资产 | $2.5B | $3.5B |
| 负债/权益比越低杠杆越低 | 0.16× | 0.86× |
8季度趋势，按日历期对齐
现金及短期投资MSMOPCH
| Q4 25 | $40.3M | — | ||
| Q3 25 | $56.2M | $309.8M | ||
| Q2 25 | $71.7M | $198.8M | ||
| Q1 25 | — | $171.4M | ||
| Q4 24 | $57.3M | $412.6M | ||
| Q3 24 | — | $483.0M | ||
| Q2 24 | $25.9M | $376.9M | ||
| Q1 24 | $22.2M | $219.5M |
总债务MSMOPCH
| Q4 25 | $214.1M | — | ||
| Q3 25 | $168.8M | $1.2B | ||
| Q2 25 | $285.0M | $1.1B | ||
| Q1 25 | — | $1.1B | ||
| Q4 24 | $289.9M | $1.1B | ||
| Q3 24 | — | $1.1B | ||
| Q2 24 | $299.8M | $1.1B | ||
| Q1 24 | $294.5M | $1.1B |
股东权益MSMOPCH
| Q4 25 | $1.4B | — | ||
| Q3 25 | $1.4B | $1.4B | ||
| Q2 25 | $1.4B | $1.4B | ||
| Q1 25 | — | $1.4B | ||
| Q4 24 | $1.4B | $1.4B | ||
| Q3 24 | — | $1.4B | ||
| Q2 24 | $1.4B | $1.4B | ||
| Q1 24 | $1.4B | $1.4B |
总资产MSMOPCH
| Q4 25 | $2.5B | — | ||
| Q3 25 | $2.5B | $3.5B | ||
| Q2 25 | $2.5B | $3.4B | ||
| Q1 25 | — | $3.3B | ||
| Q4 24 | $2.5B | $3.4B | ||
| Q3 24 | — | $3.4B | ||
| Q2 24 | $2.5B | $3.3B | ||
| Q1 24 | $2.5B | $3.2B |
负债/权益比MSMOPCH
| Q4 25 | 0.16× | — | ||
| Q3 25 | 0.12× | 0.86× | ||
| Q2 25 | 0.21× | 0.82× | ||
| Q1 25 | — | 0.82× | ||
| Q4 24 | 0.21× | 0.79× | ||
| Q3 24 | — | 0.78× | ||
| Q2 24 | 0.21× | 0.79× | ||
| Q1 24 | 0.21× | 0.74× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $29.4M | $139.4M |
| 自由现金流经营现金流 - 资本支出 | $7.4M | $130.2M |
| 自由现金流率自由现金流/营收 | 0.8% | 9.1% |
| 资本支出强度资本支出/营收 | 2.3% | 0.6% |
| 现金转化率经营现金流/净利润 | 0.57× | 2.69× |
| 过去12个月自由现金流最近4个季度 | — | $220.7M |
8季度趋势，按日历期对齐
经营现金流MSMOPCH
| Q4 25 | $29.4M | — | ||
| Q3 25 | — | $139.4M | ||
| Q2 25 | $151.6M | $90.3M | ||
| Q1 25 | — | $-7.2M | ||
| Q4 24 | $101.9M | $36.1M | ||
| Q3 24 | — | $160.4M | ||
| Q2 24 | $143.5M | $195.7M | ||
| Q1 24 | $78.7M | $-68.8M |
自由现金流MSMOPCH
| Q4 25 | $7.4M | — | ||
| Q3 25 | — | $130.2M | ||
| Q2 25 | $100.7M | $81.2M | ||
| Q1 25 | — | $-16.6M | ||
| Q4 24 | $81.7M | $25.8M | ||
| Q3 24 | — | $150.7M | ||
| Q2 24 | $114.0M | $185.9M | ||
| Q1 24 | $53.4M | $-74.6M |
自由现金流率MSMOPCH
| Q4 25 | 0.8% | — | ||
| Q3 25 | — | 9.1% | ||
| Q2 25 | 10.4% | 5.7% | ||
| Q1 25 | — | -1.2% | ||
| Q4 24 | 8.8% | 2.0% | ||
| Q3 24 | — | 11.8% | ||
| Q2 24 | 11.6% | 15.1% | ||
| Q1 24 | 5.7% | -6.5% |
资本支出强度MSMOPCH
| Q4 25 | 2.3% | — | ||
| Q3 25 | — | 0.6% | ||
| Q2 25 | 5.2% | 0.6% | ||
| Q1 25 | — | 0.7% | ||
| Q4 24 | 2.2% | 0.8% | ||
| Q3 24 | — | 0.8% | ||
| Q2 24 | 3.0% | 0.8% | ||
| Q1 24 | 2.7% | 0.5% |
现金转化率MSMOPCH
| Q4 25 | 0.57× | — | ||
| Q3 25 | — | 2.69× | ||
| Q2 25 | 2.67× | 1.79× | ||
| Q1 25 | — | -0.15× | ||
| Q4 24 | 2.18× | 0.60× | ||
| Q3 24 | — | 2.98× | ||
| Q2 24 | 2.00× | 3.69× | ||
| Q1 24 | 1.27× | -1.54× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
MSM
暂无分部数据
OPCH
| Commercial Customer | $1.3B | 87% |
| Government Customer | $172.8M | 12% |
| Patient Customer | $10.1M | 1% |
| Corporate Joint Venture | $1.9M | 0% |
